Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of HTFL is 38 and suggests 79% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell